Etodolac, a new nonsteroidal anti-inflammatory drug: Gastrointestinal microbleeding and endoscopic studies F. L. LanzaJ. D. Arnold OriginalPaper Pages: 5 - 15
Theoretical mechanism for the gastrointestinal safety of etodolac: Selective sparing of cytoprotective prostaglandins D. DvornikD. K. H. Lee OriginalPaper Pages: 16 - 24
Profile of etodolac: Pharmacokinetic evaluation in special populations D. C. BraterK. C. Lasseter OriginalPaper Pages: 25 - 35
Effects of etodolac on human chondrocytes cultivated in three dimensional culture Y. HenrotinC. BassleerP. Franchimont OriginalPaper Pages: 36 - 42
Recent clinical experience with etodolac in the treatment of osteoarthritis of the knee P. N. Platt OriginalPaper Pages: 54 - 62
International experience with etodolac therapy for rheumatoid arthritis: An interim report of comparative efficacy D. Briancon OriginalPaper Pages: 63 - 72